NYU Grossman School of Medicine is a medical school of New York University, a private research university in New York City. It was founded in 1841 and is one of two medical schools of the university, with the other being the Long Island School of Medicine.

During the past decade, New York University School of Medicine conducted 325 clinical trials. In the 10-year time frame, 325 clinical trials started and 96 clinical trials were completed, i.e. on average, 29.5% percent of trials that started reached the finish line to date. In the past 5 years, 50 clinical trials started and 74 clinical trials were completed. i.e. 148% of trials that started reached the finish line.

Out of the total clinical trials conducted in "New York University School of Medicine" #1 sponsor was "NYU Langone Health" with 316 trials, followed by "Centers for Disease Control and Prevention" with 10 trials sponsored, "Genzyme, a Sanofi Company" with 7 trials sponsored, "Johns Hopkins University" with 7 trials sponsored and "Celgene" with 7 trials sponsored. Other sponsors include 85 different institutions and companies that sponsored additional 80 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "New York University School of Medicine" #1 collaborator was "National Institutes of Health (NIH)" with 15 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 10 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 8 trials as a collaborator, "US Department of Veterans Affairs" with 8 trials as a collaborator and "NYU Langone Health" with 7 trials as a collaborator. Other collaborators include 197 different institutions and companies that were collaborators in the rest 140 trials.

According to Clinical.Site data, the most researched conditions in "New York University School of Medicine" are "Epilepsy" (9 trials), "HIV Infections" (9 trials), "Multiple Sclerosis" (9 trials), "Alzheimer Disease" (8 trials) and "Asthma" (7 trials). Many other conditions were trialed in "New York University School of Medicine" in a lesser frequency.

Most popular intervention types in "New York University School of Medicine" are "Drug" (150 trials), "Behavioral" (94 trials), "Other" (94 trials), "Device" (52 trials) and "Procedure" (37 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (30 trials), "Usual Care" (8 trials), "Standard of Care" (5 trials), "Bortezomib" (4 trials) and "Rifabutin" (4 trials). Other intervention names were less common.

The vast majority of trials in "New York University School of Medicine" are 401 trials for "All" genders, 23 trials for "Female" genders and 12 trials for "Male" genders.

Currently, there are NaN active trials in "New York University School of Medicine". undefined are not yet recruiting, 46 are recruiting, 28 are Active, not recruiting, and 4 are Enrolling by invitation. In total, there were 260 completed trials in New York University School of Medicine, 6 suspended trials, and 40 terminated clinical trials to date.

Out of the total trials that were conducted in New York University School of Medicine, 19 "Phase 1" clinical trials were conducted, 58 "Phase 2" clinical trials and 40 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 30 trials, and there were also 223 trials that are defined as “Not Applicable".